跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,096 条关于
“ATTR cardiac amyloidosis”
全部
13,096
临床试验
11,275
药物
139
机构
48
资讯
1,634
2年前
Vutrisiran Shows Promise in Reducing Hospitalization and Deaths in ATTR Cardiac Amyloidosis
去年
European Commission Grants Orphan Drug Designation to Florbetaben (18F) for ATTR Amyloidosis Diagnosis
去年
Ultromics' EchoGo® Amyloidosis Receives FDA Clearance for Cardiac Amyloidosis Detection
2年前
Alnylam's AMVUTTRA Shows Significant Cardiac Benefits in ATTR Amyloidosis Patients at ACC.25
去年
Rambam Hospital Pioneers CRISPR Gene Therapy Trial for Cardiac Amyloidosis
去年
CRISPR Gene-Editing Therapy Shows Promise in Treating Cardiac Amyloidosis
去年
Dual Diagnosis of Aortic Stenosis and Cardiac Amyloidosis Linked to Higher Mortality Risk, Study Shows
去年
FDA Grants Fast Track Designation to ALXN2220 for ATTR Amyloidosis with Cardiomyopathy
8年前
Life Molecular Imaging Secures FDA Fast Track Designation for [18F]florbetaben in Cardiac Amyloidosis Diagnosis
去年
Attralus Initiates Phase 3 Trial of 124I-evuzamitide for Cardiac Amyloidosis Diagnosis
第 1 页,共 164 页
上一页
下一页